Brooke-Spiegler syndrome
Brooke-Spiegler Syndrome is a rare genetic disorder characterized by the development of multiple skin tumors, specifically adenomas, cylindromas, and trichoepitheliomas. The syndrome is named after dermatologists Henry Ambrose Grundy Brooke and Henry Spiegler, who first described the condition.
Etiology[edit | edit source]
Brooke-Spiegler Syndrome is caused by mutations in the CYLD gene, which is located on chromosome 16. The CYLD gene is a tumor suppressor gene, meaning it helps control cell growth and prevent tumors from forming. Mutations in the CYLD gene disrupt this function, leading to the uncontrolled growth of cells and the formation of tumors.
Clinical Features[edit | edit source]
The primary clinical feature of Brooke-Spiegler Syndrome is the development of multiple skin tumors. These tumors typically begin to appear in adolescence or early adulthood and increase in number and size over time. The tumors are usually benign, but there is a risk of malignant transformation.
The most common types of tumors seen in Brooke-Spiegler Syndrome are:
- Cylindromas: These are benign tumors that typically form on the scalp and face. They are often described as having a "jigsaw puzzle" appearance.
- Trichoepitheliomas: These are benign tumors that form in the hair follicles. They typically appear on the face.
- Adenomas: These are benign tumors that can form in various parts of the body. In Brooke-Spiegler Syndrome, they typically form in the sweat glands.
Diagnosis[edit | edit source]
Diagnosis of Brooke-Spiegler Syndrome is typically based on the clinical features and a family history of the condition. Genetic testing can be used to confirm the diagnosis by identifying a mutation in the CYLD gene.
Treatment[edit | edit source]
There is currently no cure for Brooke-Spiegler Syndrome. Treatment is focused on managing the symptoms and may include surgery to remove tumors, laser therapy, or other dermatological treatments.
Prognosis[edit | edit source]
The prognosis for individuals with Brooke-Spiegler Syndrome is generally good. The tumors are usually benign and do not affect lifespan. However, the condition can significantly impact quality of life due to the cosmetic effects of the tumors and the potential for malignant transformation.
See Also[edit | edit source]
Brooke-Spiegler syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD